Gene Symbol | Pearson Correlation Coefficient |
---|---|
ATP2A3 | 0.497 |
OSR2 | 0.489 |
CD28 | 0.477 |
VCAM1 | 0.475 |
UGT2A1 | 0.471 |
GATA6 | 0.462 |
IRF6 | 0.454 |
BNC2 | 0.454 |
FOXD2 | 0.453 |
C1QTNF7 | 0.45 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
SLC22A9 | -0.247 |
PDZD9 | -0.245 |
CRIP3 | -0.242 |
TP53TG3D | -0.241 |
RHCG | -0.237 |
EFNA5 | -0.234 |
PTCHD1 | -0.234 |
SPTBN5 | -0.232 |
COLQ | -0.231 |
C20orf203 | -0.231 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CD1C mRNA | 24449571 |
C064925 | gadodiamide | gadodiamide results in increased expression of CD1C mRNA | 20959327 |
D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in increased expression of CD1C mRNA | 17183730 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD1C mRNA | 25613284 |
D009532 | Nickel | Nickel results in increased expression of CD1C mRNA | 25583101 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of CD1C mRNA | 16780908 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD1C mRNA | 25613284 |
D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in increased expression of CD1C mRNA | 17183730 |
D014810 | Vitamin E | Vitamin E results in increased expression of CD1C mRNA | 19244175 |
D015215 | Zidovudine | [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CD1C mRNA | 20370541 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0030883 | endogenous lipid antigen binding | - | IBA | 21873635 |
GO:0030883 | endogenous lipid antigen binding | - | IDA | 21167756 |
GO:0030884 | exogenous lipid antigen binding | - | IBA | 21873635 |
GO:0030884 | exogenous lipid antigen binding | - | IDA | 21167756 |
GO:0051861 | glycolipid binding | - | IDA | 21167756 |
GO:0071723 | lipopeptide binding | - | IBA | 21873635 |
GO:0071723 | lipopeptide binding | - | IDA | 21167756 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001916 | positive regulation of T cell mediated cytotoxicity | - | IBA | 21873635 |
GO:0002250 | adaptive immune response | - | IEA | - |
GO:0002286 | T cell activation involved in immune response | - | IDA | 21167756 |
GO:0006955 | immune response | - | IBA | 21873635 |
GO:0048006 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | - | IBA | 21873635 |
GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | - | IBA | 21873635 |
GO:0050776 | regulation of immune response | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005764 | lysosome | - | IEA | - |
GO:0005886 | plasma membrane | - | IBA | 21873635 |
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | TAS | 1702817 |
GO:0009986 | cell surface | - | IBA | 21873635 |
GO:0010008 | endosome membrane | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04640 | Hematopoietic cell lineage |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1280218 | Adaptive Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | TAS |